CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Increase of serum amyloid A levels during the early phase of antiviral treatment predicts sustained virologic response in patients with chronic hepatitis C
DOI 10.1055/s-0032-1313851
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Dulic, E Dulic-Lakovic, F Rieder, R Schwarzer, S Assadi, W Graninger, M Gschwantler, C Steininger
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Serum amyloid A (SAA) is an acute phase protein, which is synthesized by the liver and induced by various inflammatory stimuli, including viral infections. SAA inhibits replication of hepatitis C virus (HCV) in vitro by blocking virus entry into hepatoyctes. We therefore hypothesized that SAA levels measured during the early phases of HCV-therapy predicts the success of antiviral treatment. Material an…
Zitieren
Zitierempfehlung
M Dulic, E Dulic-Lakovic, F Rieder, R Schwarzer, S Assadi, W Graninger, M Gschwantler, C Steininger (2012) Increase of serum amyloid A levels during the early phase of antiviral treatment predicts sustained virologic response in patients with chronic hepatitis C. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0032-1313851
Mit CareLit weiterarbeiten